Table 4. Logistic (univariate and multivariate) regression analysis of factors predicting resolution of fatty changes in liver in NAFLD subjects (n=37).
Factors | OR | 95% CI | p value | AOR | 95% CI | p value |
Age (years) | 1.02 | 0.93-1.12 | 0.673 | 1.07 | 0.92-1.26 | 0.383 |
BMI (kg/m2) | 1.02 | 0.73-1.43 | 0.908 | |||
Waist circumference | 0.94 | 0.84-1.06 | 0.302 | |||
Waist hip ratio | 0.002 | 0.0001-1546 | 0.443 | |||
Waist height ratio | 0.54 | 0.0001-73566 | 0.942 | |||
SBP (mm Hg) | 0.98 | 0.95-1.01 | 0.262 | |||
DBP (mm Hg) | 1.01 | 0.93-1.07 | 0.985 | |||
FPG (mg/dL) | 0.98 | 0.96-1.01 | 0.057 | |||
PGPG (mg/dL) | 0.99 | 0.98-1.00 | 0.106 | |||
Triglycerides (mg/dL) | 0.98 | 0.96-0.99 | 0.009 | 0.58 | 0.26-1.31 | 0.189 |
Cholesterol (mg/dL) | 1.01 | 0.98-1.03 | 0.631 | |||
HDL (mg/dL) | 1.04 | 0.95-1.14 | 0.362 | |||
LDL (mg/dL) | 1.02 | 0.99-1.04 | 0.158 | |||
VLDL (mg/dL) | 0.90 | 0.83-0.98 | 0.012 | 13.84 | 0.24-80.79 | 0.205 |
Bilirubin (mg/dL) | 0.26 | 0.02-3.51 | 0.311 | |||
AST (U/L) | 1.03 | 0.98-1.08 | 0.324 | |||
ALT (U/L) | 1.01 | 0.98-1.04 | 0.340 | |||
ALP (U/L) | 1.01 | 0.99-1.02 | 0.457 | |||
GGT (U/L) | 1.01 | 0.99-1.02 | 0.490 | |||
Fasting insulin | 0.87 | 0.69-1.07 | 0.191 | |||
HOMA-IR | 0.52 | 0.24-1.11 | 0.089 | |||
Metabolic Syndrome | 4.29 | 1.06-17.36 | 0.041 | 0.910 | 0.13-6.55 | 0.926 |
Total duration of exercise | 1.01 | 0.89-1.29 | 0.978 | |||
Total calories burnt during exercise | 1.01 | 0.98-1.02 | 0.122 | |||
Exercise intensity (low vs. moderate) | 0.18 | 0.04-0.74 | 0.017 | 17.18 | 1.16-253.61 | 0.038 |
MET | 2.35 | 1.01-5.47 | 0.043 |
Abbreviations: BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FPG, fasting plasma glucose; PGPG, post-glucose load plasma glucose (after 2-h glucose load); HDL, high density lipoprotein; LDL, low density lipoprotein; VLDL, very low density lipoprotein; AST, aspartate transaminase; ALT, alanine transaminase; ALP, alkaline phosphatase; GGT, gamma-glutamyl transpeptidase; HOMA-IR, homeostatic model assessment of insulin resistance; MET, metabolic equivalent; OR, odds ratio; AOR, adjusted odds ratio; 95% CI: 95% confidence interval.